The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Stress Signals Utilize Multiple Pathways To Stabilize p53
Open accessAbstract
The p53 tumor suppressor is activated by many diverse stress signals through mechanisms that result in stabilization and accumulation of the p53 protein. p53 is normally degraded through the proteasome following interaction with MDM2, which both functions as a ubiquitin ligase for p53 and shuttles to the cytoplasm, where p53 degradation occurs. Stabilization of p53 in response to stress is associated with inhibition of MDM2-mediated degradation, which has been associated with phosphorylation of p53 in response to DNA damage or activation of ARF. In this study we show distinct responses, as measured by phosphorylation, transcriptional activity, and subcellular localization, of p53 stabilized by different activating signals. Although normal cells and wild-type p53-expressing tumor cells showed similar responses to actinomycin D and camptothecin treatment, the transcriptional activity of stabilized p53 induced by deferoxamine mesylate, which mimics hypoxia, in normal cells was lost in all three tumor cell lines tested. Our results show that multiple pathways exist to stabilize p53 in response to different forms of stress, and they may involve down-regulation of MDM2 expression or regulation of the subcellular localization of p53 or MDM2. Loss of any one of these pathways may predispose cells to malignant transformation, although reactivation of p53 might be achieved through alternative pathways that remain functional in these tumor cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
Regulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312 · cited 1×
“Degradation of p53 is regulated by interaction with the MDM2 protein (19, 28), which both functions as a ubiquitin ligase (20) and shuttles from the nucleus to the cytoplasm, where degradation of p53 is thought to take place (30, 38, 48).”
BackgroundSelf-citationMice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100
Self-citationOncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53
Honda, R., Tanaka, H., & Yasuda, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01480-4 · Cited by 1,951
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Pomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
de Oca Luna, R. M., Wagner, D. S., & Lozano, G. (1995) · Nature · doi:10.1038/378203a0 · Cited by 1,420 · cited 1×
“The importance of regulation of p53 by MDM2 during normal development is dramatically illustrated by the complete rescue of the early embryonic lethality of MDM2deficient mice by simultaneous deletion of p53 (24, 35).”
BackgroundRescue of embryonic lethality in Mdm2-deficient mice by absence of p53
Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A. (1995) · Nature · doi:10.1038/378206a0 · Cited by 1,280 · cited 1×
“The importance of regulation of p53 by MDM2 during normal development is dramatically illustrated by the complete rescue of the early embryonic lethality of MDM2deficient mice by simultaneous deletion of p53 (24, 35).”
BackgroundMyc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Research works printed but not linked: 42
- An W. G., 1998, Nature, 392, 405, 10.1038/32925 · DOI · Paper page
- Arriola E. L., 1999, Oncogene, 18, 1081, 10.1038/sj.onc.1202391 · DOI
- Ashcroft M., 1999, Oncogene, 18, 7637, 10.1038/sj.onc.1203012 · DOI · Paper page
- Banin S., 1998, Science, 281, 1674, 10.1126/science.281.5383.1674 · DOI · Paper page
- Barak Y., 1993, EMBO J., 12, 461, 10.1002/j.1460-2075.1993.tb05678.x · DOI · Paper page
- Bates S., 1998, Nature, 395, 124, 10.1038/25867 · DOI · Paper page
- Bates S., 1996, Curr. Opin. Genet. Dev., 6, 1, 10.1016/S0959-437X(96)90004-0 · DOI · Paper page
- Blattner C., 1999, Mol. Cell. Biol., 19, 3704, 10.1128/MCB.19.5.3704 · DOI · Paper page
- Blattner C., 1999, Oncogene, 18, 1723, 10.1038/sj.onc.1202480 · DOI · Paper page
- Bulavin D., 1999, EMBO J., 18, 6845, 10.1093/emboj/18.23.6845 · DOI · Paper page
- Canman C. E., 1998, Science, 281, 1677, 10.1126/science.281.5383.1677 · DOI · Paper page
- Choi J., 1999, Cell. Mol. Life Sci., 55, 38, 10.1007/s000180050268 · DOI
- de Stanchina E., 1998, Genes Dev., 12, 2434, 10.1101/gad.12.15.2434 · DOI · Paper page
- Elenbaas B., 1996, Mol. Med., 2, 439, 10.1007/BF03401903 · DOI · Paper page
- Freedman D. A., 1998, Mol. Cell. Biol., 18, 7288, 10.1128/MCB.18.12.7288 · DOI · Paper page
- Hsiang Y. H., 1985, J. Biol. Chem., 260, 14873, 10.1016/S0021-9258(17)38654-4 · DOI · Paper page
- Hupp T. R., 1994, Curr. Biol., 4, 865, 10.1016/S0960-9822(00)00195-0 · DOI · Paper page
- Kessis T. D., 1993, Proc. Natl. Acad. Sci. USA, 90, 3988, 10.1073/pnas.90.9.3988 · DOI · Paper page
- Kubbutat M. H. G., 1998, Mol. Med. Today, 4, 250, 10.1016/S1357-4310(98)01260-X · DOI
- Lain S., 1999, Exp. Cell Res., 248, 457, 10.1006/excr.1999.4433 · DOI
- Levine A. J., 1997, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 · DOI · Paper page
- Ljungman M., 1999, Oncogene, 18, 583, 10.1038/sj.onc.1202356 · DOI · Paper page
- Lohrum M. A. E., 2000, Nat. Cell Biol., 2, 179, 10.1038/35004057 · DOI · Paper page
- Middeler G., 1997, Oncogene, 14, 1407, 10.1038/sj.onc.1200949 · DOI
- Midgley C. A., 1992, J. Cell Sci., 101, 183, 10.1242/jcs.101.1.183 · DOI · Paper page
- Palmero I., 1998, Nature, 395, 125, 10.1038/25870 · DOI · Paper page
- Roth J., 1998, EMBO J., 17, 554, 10.1093/emboj/17.2.554 · DOI · Paper page
- Shaulsky G., 1990, Mol. Cell. Biol., 10, 6565
- Shaulsky G., 1991, Oncogene, 6, 2055
- Sherr C. J., 1998, Genes Dev., 12, 2984, 10.1101/gad.12.19.2984 · DOI · Paper page
- Shieh S. Y., 1999, EMBO J., 18, 1815, 10.1093/emboj/18.7.1815 · DOI · Paper page
- Stommel J. M., 1999, EMBO J., 18, 1660, 10.1093/emboj/18.6.1660 · DOI · Paper page
- Stott F., 1998, EMBO J., 17, 5001, 10.1093/emboj/17.17.5001 · DOI · Paper page
- Tao W., 1999, Proc. Natl. Acad. Sci. USA, 96, 3077, 10.1073/pnas.96.6.3077 · DOI · Paper page
- Tao W., 1999, Proc. Natl. Acad. Sci. USA, 96, 6937, 10.1073/pnas.96.12.6937 · DOI · Paper page
- Unger T., 1999, EMBO J., 18, 1805, 10.1093/emboj/18.7.1805 · DOI · Paper page
- Waldman T., 1995, Cancer Res., 55, 5187
- Weber J. D., 1999, Nat. Cell Biol., 1, 20, 10.1038/8991 · DOI · Paper page
- Wu L., 1997, Mol. Med., 3, 441, 10.1007/BF03401691 · DOI · Paper page
- Wu X. W., 1993, Genes Dev., 7, 1126, 10.1101/gad.7.7a.1126 · DOI · Paper page
- Yokoyama Y., 1992, Exp. Cell Res., 202, 77, 10.1016/0014-4827(92)90406-X · DOI
- Zhang Y., 1999, Mol. Cell, 3, 579, 10.1016/S1097-2765(00)80351-2 · DOI · Paper page
Cited by
PUMA, a Novel Proapoptotic Gene, Is Induced by p53
Nakano, K., & Vousden, K. H. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00214-3 · Cited by 2,315
Self-citationKruse, J.-P., & Gu, W. (2009) · Cell · doi:10.1016/j.cell.2009.04.050 · Cited by 1,610
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage
Maya, R., Balass, M., Kim, S.-T., Shkedy, D., Leal, J.-F. M., Shifman, O., Moas, M., Buschmann, T., Ronai, Z., Shiloh, Y., et al. (2001) · Genes & Development · doi:10.1101/gad.886901 · Cited by 731
“After the second and third rounds of biopanning, individual amplified phage clones were tested by ELISA (Balass et al. 1993) for specific binding to mAb 2A10.”
MethodRegulation of HDM2 activity by the ribosomal protein L11
Lohrum, M. A. E., Ludwig, R. L., Kubbutat, M. H. G., Hanlon, M., & Vousden, K. H. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00134-x · Cited by 623
Self-citation
Metadata
- Authors
- Ashcroft, M., Taya, Y., & Vousden, K. H.
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2000-05-01
- Volume
- 20
- Issue
- 9
- Pages
- 3224-3233
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- OpenAlex
- W2147852942
- Cited by
- 356
- References
- 18
- FWCI
- 12.29
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stress Signals Utilize Multiple Pathways To Stabilize p53. https://app.cochat.ai/papers/10.1128/mcb.20.9.3224-3233.2000
- The paper
- Ashcroft, M., Taya, Y., & Vousden, K. H. (2000). Stress Signals Utilize Multiple Pathways To Stabilize p53. Molecular and Cellular Biology. https://doi.org/10.1128/mcb.20.9.3224-3233.2000
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
